The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design.
Couty S, Westwood IM, Kalusa A, Cano C, Travers J, Boxall K, Chow CL, Burns S, Schmitt J, Pickard L, Barillari C, McAndrew PC, Clarke PA, Linardopoulos S, Griffin RJ, Aherne GW, Raynaud FI, Workman P, Jones K, van Montfort RL.
Couty S, et al. Among authors: workman p.
Oncotarget. 2013 Oct;4(10):1647-61. doi: 10.18632/oncotarget.1255.
Oncotarget. 2013.
PMID: 24072592
Free PMC article.